Oral contraceptives and thromboembolism.
D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008656:Mestranol / Q000008:administration & dosage / Q000009:adverse effects; D011247:Pregnancy; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects; D011446:Prospective Studies; D012189:Retrospective Studies; D013923:Thromboembolism / Q000139:chemically induced* / Q000401:mortality; D013924:Thrombophlebitis / Q000139:chemically induced / Q000401:mortality
D003276:Contraceptives, Oral; D004338:Drug Combinations; D004967:Estrogens; D011372:Progestins; D004997:Ethinyl Estradiol; D008656:Mestranol